Pre-filled syringe

Syaloset 2000 is a sterile, apyrogenic, viscoelastic solution produced with High Molecular Weight Hyaluronic Acid sodium salt obtained by bacterial fermentation. In traumatic and degenerative diseases of the joints, the quality of Hyaluronic Acid decreases and the synovial fluid loses viscosity, causing impairment of function and painful symptoms. Intra-articular administration of Hyaluronic Acid can restore the viscoelastic properties of the synovial fluid, with consequent alleviation of pain and an improvement in the mobility of the joint.

Syaloset 2000 is a synovial fluid substitute for patients with degenerative or mechanical arthropathy.


Syaloset 2000 is a Medical Device with viscoelastic properties consisting of 2 ml of a sterile, pyrogenic and isotonic solution containing 1.5% of High Molecular Weight Hyaluronic Acid (> 2000 kDa) obtained by bacterial fermentation.

Hyaluronic acid is a polysaccharide of the glycosaminoglycan family, naturally present in many human tissues such as cartilage and synovial fluid to which it provides its characteristic viscosity and elasticity.

Pharmaceutical form

Pre-filled syringe - 1.5% high molecular weight sodium hyaluronate solution (> 2000 kDa) - 30 mg / 2 ml


Warning: the Product's administration must be performed exclusively by medical specialists.
Aspirate any joint effusion before injecting Syaloset 2000.
Inject Syaloset 2000 into the injured joint at weekly intervals for a total of 3 weeks.

Information / Warnings

Do not freeze.
Although preclinical studies performed on laboratory animals indicate that the product has no potential for reproductive and developmental toxicity, Syaloset 2000 has not been tested in pregnant women.
Syaloset 2000 is for single use only; after use, eliminate according to the regulations in force.
Keep out of reach of children.

You may also be interested in:

River Pharma products represent progress for the Medical-Scientific Community, as well as the response to the most widespread ailments and diseases in the world.



Syalox 300 Plus is indicated in all clinical situations characterised by joint pain and reduced mobility.

Discover the product


The Synergy of the 2 Active Ingredients allow pain control in all those clinical situations characterized by Neuropathy of both joint and metabolic origin.

Discover the product

River Pharma: Healthcare is Our Passion


State-of-the-art products based on high molecular weight Hyaluronic Acid obtained through bio-fermentation technology and are characterised by their effectiveness proven in five distinct therapeutic areas.

Find out more

Medical Devices

The latest generation of medical devices based on Hyaluronic Acid with a high molecular weight, 2 mil D, to be injected, effective for the treatment and prevention of osteoarticular pathologies linked to ageing and for the treatment of acute trauma. 

Find out more


Products that contain, Hyaluronic Acids with a careful selection of molecular weight, amongst other things and are characterised by their anti-ageing effectiveness.

Find out more

Science Informs: The River Pharma Blog

Stay up to date, learn more about the research and insights of the most authoritative members of the International Medical-Scientific Community.

Menopause and osteoporosis: what causes bone loss?

Menopause and osteoporosis: what causes bone loss?

Unfortunately for all women who are in menopause osteoporosis is a sad reality that sooner or later will become increasingly present in their lives, this is even more true in all those who already have a genetic predisposition towards this degenerative bone disease.

Keep reading

Iscriviti alla nostra Newsletter

Il tuo appuntamento con la Scienza non si ferma mai. Registrati e rimani sempre aggiornato sulle notizie, gli approfondimenti, gli studi e le soluzioni terapeutiche più all’avanguardia.